MISSISSAUGA, Ontario – (COMMERCIAL THREAD) – MedX Health Corp. (“MedX“or the”Company“) (TSX-V: MDX) announces that, following acceptance by the TSX Venture Exchange, it issued 360,000 common shares at a deemed issue price of $ 0.20 per share, representing consideration total of $ 72,000, in consideration for consulting services rendered The shares were issued under the prospectus exemption contained in Regulation 45-106 S. 2.24; subject to the criteria contained in Regulation 45-102 Article 2.6 (3) being respected, the shares are not subject to any restrictive holding period.
MedX, headquartered in Mississauga, Ontario, is a leading medical device and software company focused on skin health with its SIAscopy® on DermSecure® telemedicine platform, using its SIAscopy® Technology. SIAscopy® is also integrated in SIAMETRICS®, a reputable research system used to assess the effectiveness of treatment for various skin conditions, including burns. The company’s SIAscope® and other devices are manufactured in its ISO 13485 certified factory. The SIAscope® is a hand-held device that uses patented technology using light and its transfer to visualize up to 2mm below suspicious moles and lesions in a painless and non-invasive manner, with the company’s software then creating real-time images for doctors and dermatologists to assess all types of moles or lesions in seconds. These products are approved by Health Canada, FDA, TGA, and CE for use in Canada, United States, Australia, New Zealand, European Union, Turkey, and Brazil. DermSecure® meets all relevant privacy, security and regulatory requirements in Canada, US, Brazil, and EU. MedX also designs, manufactures and distributes quality therapeutic and dental photobiomodulation lasers to provide drug-free and non-invasive treatment of tissue damage and pain. www.medxhealth.com
This press release does not constitute an offer to sell any securities. This press release contains certain forward-looking statements within the meaning of applicable Canadian securities laws. These forward-looking statements involve certain risks and uncertainties that could cause actual results to vary, including, without limitation, the company’s limited operating history and loss history, inability to successfully obtain additional financing, inability to raise capital on terms acceptable to the business, inability to compete effectively in the market, inability to complete the proposed acquisition and other risks which could cause actual results differ materially from those contained in the company’s projections or forward-looking statements. All forward-looking statements contained in this press release are based on information available to the company as of the date hereof, and the company does not undertake to update any forward-looking statements to reflect events or circumstances occurring after the release. date of this press release.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.